Viewing nowCombinationDulabr Tablet 60/5 mg (Pimasartan Potassium, Esamlodipine)
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.

MFDS item code 202300090 · Approved 2023.01.06 · Insurance code 662504820
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
This medication is used in patients with essential hypertension when controlling blood pressure with pimasartan potassium alone is difficult, by combining with additional treatments or other medications to control blood pressure.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan. However, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is necessary in elderly patients aged 70 years or younger. No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. No dose adjustment is necessary in patients with mild hepatic impairment. This medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.
This medication can cause serious harm to the fetus or newborn, especially when taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. This medication should not be used by individuals who have allergies to its main ingredients or similar classes of drugs, are pregnant or breastfeeding, are undergoing kidney dialysis, have moderate to severe liver impairment, have biliary obstruction, or have specific kidney diseases or diabetic nephropathy. Patients with low blood volume or reduced sodium levels, impaired kidney function, renovascular hypertension, aortic stenosis, severe hypotension, and the elderly should use this medication with particular caution and be closely monitored during treatment. Side effects such as dizziness, headaches, facial swelling, urinary issues, insomnia, and flushing may occur; if symptoms are severe, consult a physician. Symptoms of hypotension may occur due to excessively low blood pressure, so those taking diuretics or with low sodium intake in their diet should closely monitor for symptoms of hypotension and seek appropriate treatment if necessary. This medication may increase potassium levels in the blood; therefore, patients with heart failure or impaired kidney function should regularly check their potassium levels through blood tests. Interactions may occur if this medication is taken with other antihypertensives or certain medications, so if other medications are being taken, it is crucial to inform healthcare professionals. Pregnant or breastfeeding women are advised to avoid this medication, especially since it may pose risks to the fetus during pregnancy; consultation with healthcare professionals is essential before use. The safety and efficacy in children and adolescents under 18 years have not been established, so it is advisable not to use this medication in this age group. In cases of overdose, severe hypotension or abnormalities in heart function may occur, and immediate contact with a medical institution is necessary for appropriate treatment. This medication should be stored out of reach of children and not transferred to other containers; it is important to carefully check the precautions during use.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it should be kept at room temperature, preferably between 1 to 30 degrees Celsius, avoiding extremes in temperature.
Orange, rounded square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.